Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02248935 · ClinicalTrials.gov registry record
Comparison of 2 Lightweight Y-meshes After Laparoscopic Sacrocolpopexy
A clinical trial of Pelvic Organ Prolapse, sponsored by Atlantic Health System.
- Completed
- Registry status
- 316
- Enrollment target
- 1
- Study location
NCT02248935: Completed study of Pelvic Organ Prolapse, sponsored by Atlantic Health System.
NCT02248935 is a study of Pelvic Organ Prolapse that has completed, run by Atlantic Health System. The registered enrollment target is 316 participants, above the 137-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (131% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02248935, a study of Pelvic Organ Prolapse, has completed, sponsored by Atlantic Health System.
- COMPLETED
- Registry status
- 316 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine the clinical cure rates of pelvic organ prolapse from subjects that had a robotic-assisted sacrocolpopexy using Alyte Y mesh and Restorelle Y smartmesh lightweight mesh.
Primary Outcome
To be considered a "clinical cure" subjects must meet all of the following criteria: no re-operation for or non-surgical treatment of pelvic organ prolapse since the index surgery; no symptoms of vaginal bulge as measured by a validated symptom questionnaire; no Pelvic Organ Prolapse Quantification (POP-Q) points greater than 0; POP-Q point C less than or equal to -5; an answer of "satisfied" or "very satisfied" on validated Surgical Satisfaction Questionnaire
Conditions Studied
Study Locations (1)
New Jersey
- Department of Urogynecology-Atlantic Health System - Morristown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 316 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-08 |
What the finished NCT02248935 record still lists
NCT02248935 is an observational study that tracks outcomes without assigning an intervention. The registered 316 participants enrollment target is mid-sized for trials with a published cap, above the 137-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (131% higher).
The record links to 1 condition, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 0 interventions.
NCT02248935 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02248935 about?
NCT02248935 is a clinical study titled "Comparison of 2 Lightweight Y-meshes After Laparoscopic Sacrocolpopexy". The purpose of the study is to determine the clinical cure rates of pelvic organ prolapse from subjects that had a robotic-assisted sacrocolpopexy using Alyte Y mesh and Restorelle Y smartmesh lightweight mesh.
What is the current status of trial NCT02248935?
This trial is currently completed. The enrollment target is 316 participants. The study started on 2014-07. Estimated completion is 2015-08.
What conditions does trial NCT02248935 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse.
Who is sponsoring clinical trial NCT02248935?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02248935 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02248935's enrollment target sits among peer trials
316 3rd of 40 higher than 38 of 40 other Pelvic Organ Prolapse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pelvic Organ Prolapse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Centered Surgery - Preoperative Counseling and Patient Satisfaction
RECRUITING
-
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
RECRUITING
-
Pessary Experience Study
RECRUITING
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
-
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04256317 · 316 participants · Phase 2
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- NCT04787042 · 316 participants · Phase 1
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- NCT04802759 · 316 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- NCT05464056 · 316 participants · NA
BUILT Family Lifestyle Program for Children with ADHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia